Insulin-induced hypoglycemia and stress oxidative state in healthy people

Gholamreza Yousefzade1, Akram Nakhaee

  • 1Kerman Physiology Research Center, Kerman University of Medical Sciences and Health Services, Kerman, Iran. ghyousefzadeh@yahoo.com

Acta Diabetologica
|October 11, 2011
PubMed

Insights

Insulin-induced hypoglycemia significantly increases oxidative stress markers like malondialdehyde and decreases antioxidant capacity, total thiol groups, and superoxide dismutase activity in healthy young men.

Area of Science:

  • Biochemistry
  • Human Physiology
  • Oxidative Stress Research

Background:

  • Oxidative stress plays a role in various physiological and pathological processes.
  • Understanding the impact of acute metabolic changes on antioxidant systems is crucial.

Purpose of the Study:

  • To investigate the immediate effects of insulin-induced hypoglycemia on key oxidative stress biomarkers.
  • To assess changes in superoxide dismutase activity, malondialdehyde, total antioxidant capacity, and thiol groups.

Main Methods:

  • A clinical trial involving 16 healthy adult males.
  • Hypoglycemia was induced via intravenous insulin administration (0.1 U/kg).
  • Measurements included superoxide dismutase (SOD) activity, malondialdehyde (MDA) via TBARS assay, total thiol concentration (HPLC), and ferric reducing/antioxidant power (FRAP).

Main Results:

  • Insulin-induced hypoglycemia significantly increased TBARS levels (MDA).
  • A significant decrease was observed in antioxidant power (FRAP value), total thiol concentration, and SOD enzyme activity.
  • P-values < 0.001 for TBARS, FRAP, and SOD; P = 0.001 for total thiol concentration.

Conclusions:

  • Acute hypoglycemia acutely impairs the body's antioxidant defense mechanisms.
  • These findings highlight the pro-oxidative state induced by rapid glucose reduction.

Related Concept Videos

Hypoglycemia01:26

Hypoglycemia

Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
Hyperglycemia01:29

Hyperglycemia

Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
Glucose Homeostasis: Regulation of Blood Glucose01:02

Glucose Homeostasis: Regulation of Blood Glucose

Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...